Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug;8(4):325-36.
doi: 10.1007/s11938-005-0026-8.

Treatment of functional dyspepsia

Affiliations

Treatment of functional dyspepsia

Smita L S Halder et al. Curr Treat Options Gastroenterol. 2005 Aug.

Abstract

Functional dyspepsia (FD) is a common reason a patient presents with upper gastrointestinal symptoms for medical care. Although treatment of FD remains expensive, the agents are rarely used in a systematic manner; the majority of treatments are empirical and the results short lived once therapy is ceased. This is partly due to the lack of consistent pathophysiologic markers in FD, so therapy is symptom driven. This review appraises the best evidence on available interventions. A structured scheme for deciding on appropriate therapies is to consider the possible putative pathophysiologic mechanisms. Eradicating Helicobacter pylori, if present, is a first-line strategy. In patients who have symptoms suggesting excessive gastric acid secretion, particularly epigastric pain, antisecretory agents are recommended. Prokinetics may confer benefits on symptoms suggestive of upper gastrointestinal dysmotility, like fullness or early satiety. However, their use is limited due to availability issues. The expanding field of psychologic therapies provides a promising avenue of treatment. Complementary medicines are now widely use and their benefits have been suggested in recent controlled trials. Emerging treatments include cholecystokinin 1 blockers, opioid receptor agonists, and serotonergic agents, although their application in FD is in the preliminary stages.

PubMed Disclaimer

References

    1. Psychopharmacology (Berl). 1989;99(1):1-7 - PubMed
    1. Aliment Pharmacol Ther. 2003 Dec;18(11-12):1099-105 - PubMed
    1. Gastroenterology. 2004 Oct;127(4):1058-66 - PubMed
    1. Scand J Gastroenterol. 1988 Jan;23(1):7-18 - PubMed
    1. Gut. 2001 Mar;48(3):347-55 - PubMed

LinkOut - more resources